GlycoMimetics Appoints Edwin Rock, M.D., Ph.D. as Chief Medical Officer
“We are thrilled to have Ed join the
As CMO at Partner Therapeutics,
About Uproleselan
Discovered and developed by
About
Forward-Looking Statements
This press release contains forward-looking statements. These forward-looking statements may include, but are not limited to, statements regarding data from clinical trials, planned or potential clinical development, regulatory interactions and submissions, and the potential commercialization of the Company’s drug candidates. Actual results may differ materially from those described in these forward-looking statements. For a further description of the risks associated with these statements, as well as other risks facing
View source version on businesswire.com: https://www.businesswire.com/news/home/20220906005157/en/
Investors:
212-600-1902
Glycomimetics@argotpartners.com
Source: